Zimmer Biomet Holdings, Inc. ZBH
91.04
1.35
1.51%
as of 25 Sep
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Zimmer Biomet Holdings, Inc. (ZBH) Free cash flow margin
Zimmer Biomet Holdings, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 12.2%, down 1.4 percentage points from fiscal 2025 (13.6%). Over the past ten years it has ranged from 6.93% (fiscal 2015) to 16.5% (fiscal 2018); the current reading is higher than 64% of that period. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 13.6% | 1.85 |
| FY2024 | 11.8% | (0.09) |
| FY2023 | 11.8% | (0.84) |
| FY2022 | 12.7% | (1.66) |
| FY2021 | 14.3% | 2.85 |
| FY2020 | 11.5% | 0.65 |
| FY2019 | 10.8% | (5.65) |
| FY2018 | 16.5% | 2.53 |
| FY2017 | 14.0% | (0.41) |
| FY2016 | 14.4% | 7.44 |
Against its own ten years
Low 6.93%
High 16.5%
Ten-year median
12.7%
Current reading's percentile
64
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| GMED Globus Medical, Inc. compare | 24.0% |
| STE STERIS plc compare | 15.5% |
| PEN Penumbra, Inc. compare | 14.4% |
| BIO Bio-Rad Laboratories, Inc. compare | 13.6% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 13.6% |
| ZBH Zimmer Biomet Holdings, Inc. | 12.2% |
| PHG Koninklijke Philips N.V. compare | 8.99% |
| GEHC GE HealthCare Technologies Inc. compare | 7.42% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −7.24% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement